Hussein Hijazi

Papers

Total Citations

H-Index

About

Hussein Hijazi is a urologic oncologist whose research centers on optimizing surgical outcomes for bladder cancer patients, with a particular focus on robotic-assisted techniques and perioperative care. His work investigates the interplay between neoadjuvant chemotherapy (NAC) and robotic radical cystectomy (RRC), a critical area given the increasing use of multimodal therapy for muscle-invasive bladder cancer. In his most-cited study, Hijazi conducted a retrospective review of 134 patients to evaluate how NAC impacts short-term complications following RRC. This work provides valuable data for surgeons weighing the benefits of chemotherapy against potential surgical risks, helping to refine patient selection and perioperative management. While his citation count is still building, his research addresses a clinically relevant gap in the literature, offering evidence that can directly influence treatment protocols. Hijazi’s contributions are particularly notable for their focus on real-world outcomes, bridging the gap between clinical trials and daily practice. As robotic surgery becomes more prevalent, his findings on complication rates and recovery trajectories are essential for improving patient counseling and surgical planning in high-volume centers.